Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Case ReportImages in Rheumatology

Hydroxychloroquine-induced Hyperpigmentation

Amir Bajoghli, Gabriela Hernandez and Michael A. Cardis
The Journal of Rheumatology November 2020, 47 (11) 1721-1722; DOI: https://doi.org/10.3899/jrheum.200138
Amir Bajoghli
Skin & Laser Surgery Center, McLean, and INOVA Fairfax Hospital, Falls Church, Virginia;
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriela Hernandez
Skin & Laser Surgery Center, McLean, Virginia;
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael A. Cardis
Medstar Washington Hospital Center/Georgetown University Hospital, Washington, DC, USA.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael A. Cardis
  • For correspondence: michael.a.cardis@medstar.net
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

About 10–25% of patients with systemic lupus erythematosus (SLE) managed with antimalarials will develop cutaneous hyperpigmentation, and although the majority of such cases is attributed to chloroquine, hydroxychloroquine (HCQ) is also implicated and is likely underrecognized1.

A 52-year-old Hispanic woman with SLE and endstage renal disease receiving peritoneal dialysis presented with a 3-month history of asymptomatic, progressive darkening of her bilateral upper extremities. There was no antecedent trauma or preceding skin eruption. She had been taking HCQ 200 mg daily for 12 years. Physical examination revealed diffuse mottled and reticular hyperpigmentation with adjacent areas of ecchymosis on the bilateral upper extremities (Figure 1A). A biopsy revealed dermal deposits of iron and melanin (Figure 1B–D). A diagnosis of drug-induced dyschromia was made with a staining pattern compatible with that of antimalarial exposure.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A. Mottled and reticular hyperpigmented patches on the arms with focal ecchymosis. B. High-magnification H&E-stained section (original magnification ×400) showing scattered pigmented granules within the mid dermis, some seen within histiocytes. C–D. Perls’ Prussian blue (original magnification ×100) and Fontana Masson (original magnification ×400) stains reveal significant iron and melanin deposits within the dermis, respectively.

Presentation on the lower legs, especially shins, is classic, but other sites may be involved including mucosa and nail beds2. The pigmentation may begin within a year of treatment, but the timing of onset is variable, and contrary to HCQ-associated retinopathy, a direct association between cumulative dose or duration of therapy with the pigmentation has not been substantiated1. The pathophysiology is not well understood, but it is thought that the pigmentation is precipitated by bruising leading to hemosiderin deposition and subsequent activation of melanocytes leading to the accumulation of melanin. This hypothesis, however, is inadequate because it does not account for pigmentation on nontraumatic sites such as mucosa. Upon cessation of HCQ, some patients demonstrate partial improvement, and laser treatments may improve residual dyschromia3.

Footnotes

  • Written consent for publication of the photos herein has been waived because they are nonidentifiable. Institutional review board approval has been waived because this is a case report involving a single patient case that does not meet the US Department of Health and Human Services definition of “research.”

REFERENCES

  1. 1.↵
    1. Bahloul E,
    2. Jallouli M,
    3. Garbaa S,
    4. Marzouk S,
    5. Masmoudi A,
    6. Turki H,
    7. et al.
    Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases. Lupus 2017;26:1304–8.
    OpenUrl
  2. 2.↵
    1. Jallouli M,
    2. Francès C,
    3. Piette JC,
    4. Huong DL,
    5. Moguelet P,
    6. Factor C,
    7. et al.
    Hydroxychloroquine-induced pigmentation in patients with systemic lupus erythematosus. JAMA Dermatol 2013;149:935–40.
    OpenUrl
  3. 3.↵
    1. Coulombe J,
    2. Boccara O
    . Hydroxychloroquine-related skin discoloration. CMAJ 2017;189:E212.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 47, Issue 11
1 Nov 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hydroxychloroquine-induced Hyperpigmentation
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hydroxychloroquine-induced Hyperpigmentation
Amir Bajoghli, Gabriela Hernandez, Michael A. Cardis
The Journal of Rheumatology Nov 2020, 47 (11) 1721-1722; DOI: 10.3899/jrheum.200138

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Hydroxychloroquine-induced Hyperpigmentation
Amir Bajoghli, Gabriela Hernandez, Michael A. Cardis
The Journal of Rheumatology Nov 2020, 47 (11) 1721-1722; DOI: 10.3899/jrheum.200138
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • IgG4-Related Arterial Disease: An Unusual Case of Aortitis
  • Uncommon Clinical and Radiological Presentation of Monosodium Urate Crystal Deposition in Parotid Glands
  • Pyoderma Gangrenosum-Associated Autoinflammatory Syndrome With Skin Abscesses: Successful Treatment With Anti-Interleukin 1 Therapy
Show more Images in Rheumatology

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire